Videos

Glaucoma-Leader-Lewis-Says-MIGS-Has-Changed-Everything,-But-Much-More-to-Do

Glaucoma Leader Lewis Says MIGS Has Changed Everything, But Much More to Do

By Mario Admin | June 7, 2017

Richard Lewis, MD, founder of Sacramento Eye Consultants, says the arrival of MIGS has completely changed how physicians can treat glaucoma. In this interview, Lewis…

Read More
Sun-Pharma’s-St.-Peter-Says-Entry-into-Ophthalmology-Going-Strong

Sun Pharma’s St. Peter Says Entry into Ophthalmology Going Strong

By Mario Admin | June 7, 2017

Jerry St. Peter, VP & head, ophthalmic business, says the ophthalmology newcomer is making great progress in building broad pipeline to treat eye disease including…

Read More
Novartis’-Guerard-Updates-on-Moves-into-Presbyopia,-Dry-Eye

Novartis’ Guerard Updates on Moves into Presbyopia, Dry Eye

By Mario Admin | June 7, 2017

Frederic Guerard, worldwide business franchise head, ophthalmology, explains how the pharmaceutical giant came to make large bets in presbyopia and dry eye. “I’d like to…

Read More

Attias Shares Alcon’s View on Presbyopia, Updates on Cypass

By Mario Admin | June 7, 2017

Laurent Attias, head, strategy, BD&L and M&A, updates OIS-TV on the progress of Cypass, Alcon’s big bet in glaucoma. He also updates on the company’s…

Read More
Yeu-Hits-Upon-Highpoints-of-Presbyopia-Treatments,-Challenges-Facing-Practices

Yeu Hits Upon Highpoints of Presbyopia Treatments, Challenges Facing Practices

By Mario Admin | June 7, 2017

Elizabeth Yeu, MD, of Virginia Eye Consultants, updates OIS-TV on advances in presbyopia and dry eye that impact patients the most. She also reveals the…

Read More
J&J’s-Tom-Frinzi-Shares-the-Secrets-of-Healthy-Consolidation

J&J’s Tom Frinzi Shares the Secrets of Healthy Consolidation

By Mario Admin | June 7, 2017

Tom Frinzi, worldwide president, surgical, Johnson & Johnson Vision, says the cultural fit of Johnson & Johnson and Abbott Medical Optics helped ease the merger…

Read More
Donnenfeld-Updates-on-Dry-Eye,-Impact-on-Practices

Donnenfeld Updates on Dry Eye, Impact on Practices

By Mario Admin | June 6, 2017

Eric Donnenfeld, MD, founding partner of OCLI, shares how his practice is incorporating new diagnostics and treatments. “I spend less time diagnosing the disease and…

Read More
Shire’s-Sternberg-Speaks-to-Success-of-Xiidra-Launch

Shire’s Sternberg Speaks to Success of Xiidra Launch

By Mario Admin | June 6, 2017

Perry Sternberg, head of US commercial at Shire, updates OIS-TV on the progress of Shire’s dry eye blockbuster, Xiidra, and its growing ophthalmic pipeline. He…

Read More
Aerie-COO-Mitro-Provides-Staffing-Pipeline-Update

Aerie COO Mitro Provides Staffing, Pipeline Update

By Mario Admin | May 31, 2017

In this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says the new hires brought on to prepare for commercial sale of Rhopressa bring new life…

Read More
Zeiss-CEO-Discusses-New-Leadership-SMILE-and-the-Future-of-Dx

Zeiss CEO Discusses New Leadership, SMILE, and the Future of Dx

By Mario Admin | May 24, 2017

Ludwin Monz, PhD, president and CEO of Carl Zeiss Meditec, explains why the ophthalmology leader brought in new senior leadership. He also reviews the company’s…

Read More
Epitropoulos Shares Dry Eye Insights

Epitropoulos Shares Dry Eye Insights

By Mario Admin | May 17, 2017

Alice Epitropoulos, MD, of Ophthalmic Surgeons & Consultants of Ohio, sat down with OIS-TV to explain how Shire, TrueTear and other advances are impacting her…

Read More
OIS Index 2017 update

OIS Index Six-Month Review

By Mario Admin | May 12, 2017

Michael Lachman, president of EyeQ Research, delivers an update regarding the OIS Index. Given some of the disappointing clinical news in recent months, it’s no…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.